LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 8734

Search options

  1. Article ; Online: Deep learning-based amyloid PET positivity classification model in the Alzheimer’s disease continuum by using 2-[18F]FDG PET

    Suhong Kim / Peter Lee / Kyeong Taek Oh / Min Soo Byun / Dahyun Yi / Jun Ho Lee / Yu Kyeong Kim / Byoung Seok Ye / Mi Jin Yun / Dong Young Lee / Yong Jeong / the Alzheimer’s Disease Neuroimaging Initiative / the KBASE Research Group

    EJNMMI Research, Vol 11, Iss 1, Pp 1-

    2021  Volume 14

    Abstract: ... for the Early diagnosis and prediction of Alzheimer’s disease for model development. Moreover, we used an independent ... PET) in patients with dementia, we proposed a deep learning (DL)-based amyloid PET positivity ... classification model from PET images with 2-deoxy-2-[fluorine-18]fluoro-D-glucose (2-[18F]FDG). Methods We used 2 ...

    Abstract Abstract Background Considering the limited accessibility of amyloid position emission tomography (PET) in patients with dementia, we proposed a deep learning (DL)-based amyloid PET positivity classification model from PET images with 2-deoxy-2-[fluorine-18]fluoro-D-glucose (2-[18F]FDG). Methods We used 2-[18F]FDG PET datasets from the Alzheimer's Disease Neuroimaging Initiative and Korean Brain Aging Study for the Early diagnosis and prediction of Alzheimer’s disease for model development. Moreover, we used an independent dataset from another hospital. A 2.5-D deep learning architecture was constructed using 291 submodules and three axes images as the input. We conducted the voxel-wise analysis to assess the regions with substantial differences in glucose metabolism between the amyloid PET-positive and PET-negative participants. This facilitated an understanding of the deep model classification. In addition, we compared these regions with the classification probability from the submodules. Results There were 686 out of 1433 (47.9%) and 50 out of 100 (50%) amyloid PET-positive participants in the training and internal validation datasets and the external validation datasets, respectively. With 50 times iterations of model training and validation, the model achieved an AUC of 0.811 (95% confidence interval (CI) of 0.803–0.819) and 0.798 (95% CI, 0.789–0.807) on the internal and external validation datasets, respectively. The area under the curve (AUC) was 0.860 when tested with the model with the highest value (0.864) on the external validation dataset. Moreover, it had 75.0% accuracy, 76.0% sensitivity, 74.0% specificity, and 75.0% F1-score. We found an overlap between the regions within the default mode network, thus generating high classification values. Conclusion The proposed model based on the 2-[18F]FDG PET imaging data and a DL framework might successfully classify amyloid PET positivity in clinical practice, without performing amyloid PET, which have limited accessibility.
    Keywords Alzheimer’s disease ; Amyloid ; Dementia ; 2-[18F]FDG PET ; Deep learning ; Classification model ; Medical physics. Medical radiology. Nuclear medicine ; R895-920
    Subject code 006
    Language English
    Publishing date 2021-06-01T00:00:00Z
    Publisher SpringerOpen
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  2. Article ; Online: Prediction of Conversion from Mild Cognitive Impairment to Alzheimer’s Disease Using Amyloid PET and Brain MR Imaging Data

    Do-Hoon Kim / Minyoung Oh / Jae Seung Kim

    Diagnostics, Vol 13, Iss 21, p

    A 48-Month Follow-Up Analysis of the Alzheimer’s Disease Neuroimaging Initiative Cohort

    2023  Volume 3375

    Abstract: ... its significance in predicting the conversion from mild cognitive impairment (MCI) to Alzheimer’s disease (AD ... in the Alzheimer’s Disease Neuroimaging Initiative (ADNI) cohort. From the ADNI database, 334 patients with MCI were included ... subscale of the Alzheimer’s Disease Assessment Scale (ADAS-cog), apolipoprotein E (APOE), standardized ...

    Abstract We developed a novel quantification method named “shape feature” by combining the features of amyloid positron emission tomography (PET) and brain magnetic resonance imaging (MRI) and evaluated its significance in predicting the conversion from mild cognitive impairment (MCI) to Alzheimer’s disease (AD) in the Alzheimer’s Disease Neuroimaging Initiative (ADNI) cohort. From the ADNI database, 334 patients with MCI were included. The brain amyloid smoothing score (AV45_BASS) and brain atrophy index (MR_BAI) were calculated using the surface area and volume of the region of interest in AV45 PET and MRI. During the 48-month follow-up period, 108 (32.3%) patients converted from MCI to AD. Age, Mini-Mental State Examination (MMSE), cognitive subscale of the Alzheimer’s Disease Assessment Scale (ADAS-cog), apolipoprotein E (APOE), standardized uptake value ratio (SUVR), AV45_BASS, MR_BAI, and shape feature were significantly different between converters and non-converters. Univariate analysis showed that age, MMSE, ADAS-cog, APOE, SUVR, AV45_BASS, MR_BAI, and shape feature were correlated with the conversion to AD. In multivariate analyses, high shape feature, SUVR, and ADAS-cog values were associated with an increased risk of conversion to AD. In patients with MCI in the ADNI cohort, our quantification method was the strongest prognostic factor for predicting their conversion to AD.
    Keywords positron emission tomography ; magnetic resonance imaging ; Alzheimer’s disease ; shape feature ; Alzheimer’s disease neuroimaging initiative cohort ; Medicine (General) ; R5-920
    Subject code 610 ; 616
    Language English
    Publishing date 2023-11-01T00:00:00Z
    Publisher MDPI AG
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  3. Article ; Online: PET-validated EEG-machine learning algorithm predicts brain amyloid pathology in pre-dementia Alzheimer’s disease

    Nam Heon Kim / Ukeob Park / Dong Won Yang / Seong Hye Choi / Young Chul Youn / Seung Wan Kang

    Scientific Reports, Vol 13, Iss 1, Pp 1-

    2023  Volume 12

    Abstract: Abstract Developing reliable biomarkers is important for screening Alzheimer’s disease (AD) and ... not validated with Aβ PET scan. We developed EEG-ML algorithm to detect brain Aβ pathology ... PET. 19-channel resting-state EEG and Aβ PET were collected from 311 subjects: 196 SCD(36 Aβ +, 160 Aβ ...

    Abstract Abstract Developing reliable biomarkers is important for screening Alzheimer’s disease (AD) and monitoring its progression. Although EEG is non-invasive direct measurement of brain neural activity and has potentials for various neurologic disorders, vulnerability to noise, difficulty in clinical interpretation and quantification of signal information have limited its clinical application. There have been many research about machine learning (ML) adoption with EEG, but the accuracy of detecting AD is not so high or not validated with Aβ PET scan. We developed EEG-ML algorithm to detect brain Aβ pathology among subjective cognitive decline (SCD) or mild cognitive impairment (MCI) population, and validated it with Aβ PET. 19-channel resting-state EEG and Aβ PET were collected from 311 subjects: 196 SCD(36 Aβ +, 160 Aβ −), 115 MCI(54 Aβ +, 61Aβ −). 235 EEG data were used for training ML, and 76 for validation. EEG features were standardized for age and sex. Multiple important features sets were selected by 6 statistics analysis. Then, we trained 8 multiple machine learning for each important features set. Meanwhile, we conducted paired t-test to find statistically different features between amyloid positive and negative group. The best model showed 90.9% sensitivity, 76.7% specificity and 82.9% accuracy in MCI + SCD (33 Aβ +, 43 Aβ −). Limited to SCD, 92.3% sensitivity, 75.0% specificity, 81.1% accuracy (13 Aβ +, 24 Aβ −). 90% sensitivity, 78.9% specificity and 84.6% accuracy for MCI (20 Aβ +, 19 Aβ −). Similar trends of EEG power have been observed from the group comparison between Aβ + and Aβ −, and between MCI and SCD: enhancement of frontal/ frontotemporal theta; attenuation of mid-beta in centroparietal areas. The present findings suggest that accurate classification for beta-amyloid accumulation in the brain based on QEEG alone could be possible, which implies that QEEG is a promising biomarker for beta-amyloid. Since QEEG is more accessible, cost-effective, and safer than amyloid PET, QEEG-based biomarkers ...
    Keywords Medicine ; R ; Science ; Q
    Subject code 616
    Language English
    Publishing date 2023-06-01T00:00:00Z
    Publisher Nature Portfolio
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  4. Article ; Online: Simple Quantification of Surface Uptake in F-18 Florapronol PET/CT Imaging for the Validation of Alzheimer’s Disease

    Do-Hoon Kim / Junik Son / Chae Moon Hong / Ho-Sung Ryu / Shin Young Jeong / Sang-Woo Lee / Jaetae Lee

    Diagnostics, Vol 12, Iss 132, p

    2022  Volume 132

    Abstract: ... between patients with Alzheimer’s disease (AD) and patients with mild cognitive impairment or ... positron emission tomography–computed tomography (PET/CT) and evaluated its sensitivity and specificity for discriminating ... index (BAI) using the surface area and volume of the region of interest in PET images. We calculated ...

    Abstract We developed a novel quantification method named shape feature using F-18 florapronol positron emission tomography–computed tomography (PET/CT) and evaluated its sensitivity and specificity for discriminating between patients with Alzheimer’s disease (AD) and patients with mild cognitive impairment or other precursors dementia (non-AD). We calculated the cerebral amyloid smoothing score (CASS) and brain atrophy index (BAI) using the surface area and volume of the region of interest in PET images. We calculated gray and white matter from trained CT data, prepared using U-net. Shape feature was calculated by multiplying CASS with BAI scores. We measured region-based standard uptake values (SUVr) and performed receiver operating characteristic (ROC) analysis to compare SUVr, shape feature, CASS, and BAI score. We investigated the relationship between shape feature and neuropsychological tests. Fifty subjects (23 with AD and 27 with non-AD) were evaluated. SUVr, shape feature, CASS, and BAI score were significantly higher in patients with AD than in those with non-AD. There was no statistically significant difference between shape feature and SUVr in ROC analysis. Shape feature correlated well with mini-mental state examination scores. Shape feature can effectively quantify beta-amyloid deposition and atrophic changes in the brain. These results suggest that shape feature is useful in the diagnosis of AD.
    Keywords beta-amyloid ; positron emission tomography ; F-18 florapronol ; Alzheimer’s disease ; cerebral amyloid smoothing score ; brain atrophy index ; Medicine (General) ; R5-920
    Language English
    Publishing date 2022-01-01T00:00:00Z
    Publisher MDPI AG
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  5. Article ; Online: Dual-phase 18F-florbetaben PET provides cerebral perfusion proxy along with beta-amyloid burden in Alzheimer’s disease

    Hai-Jeon Yoon / Bom Sahn Kim / Jee Hyang Jeong / Geon Ha Kim / Hee Kyung Park / Min Young Chun / Seunggyun Ha

    NeuroImage: Clinical, Vol 31, Iss , Pp 102773- (2021)

    2021  

    Abstract: ... to the progression of Alzheimer’s disease (AD) by using a dual-phase 18F-florbetaben (FBB) PET protocol. Methods ... mild cognitive impairment (Aβ+MCI), and 16 with Aβ-positive AD (Aβ+AD), were enrolled. A dynamic PET scan was obtained ... analyses of the images were performed. The associations between cognitive profiles and PET-derived ...

    Abstract Background: This study investigated changes in brain perfusion and Aβ burden according to the progression of Alzheimer’s disease (AD) by using a dual-phase 18F-florbetaben (FBB) PET protocol. Methods: Sixty subjects, including 12 with Aβ-negative normal cognition (Aβ−NC), 32 with Aβ-positive mild cognitive impairment (Aβ+MCI), and 16 with Aβ-positive AD (Aβ+AD), were enrolled. A dynamic PET scan was obtained in the early phase (0–10 min, eFBB) and delayed phase (90–110 min, dFBB), which were then averaged into a single frame, respectively. In addition to the averaged eFBB, an R1 parametric map was calculated from the eFBB scan based on a simplified reference tissue model (SRTM). Between-group regional and voxel-wise analyses of the images were performed. The associations between cognitive profiles and PET-derived parameters were investigated. Results: Both the R1 and eFBB perfusion reductions in the cortical regions were not significantly different between the Aβ−NC and Aβ+MCI groups, while they were significantly reduced from the Aβ+MCI to Aβ+AD groups in regional and voxel-wise analyses. However, cortical Aβ depositions on dFBB were not significantly different between the Aβ+MCI and Aβ+AD groups. There were strong positive correlations between the R1 and eFBB images in regional and voxel-wise analyses. Both perfusion components showed significant correlations with general and specific cognitive profiles. Conclusion: The results of this study demonstrated the feasibility of dual-phase 18F-FBB PET to evaluate different trajectories of dual biomarkers for neurodegeneration and Aβ burden over the course of AD. In addition, both eFBB and SRTM-based R1 can provide robust indices of brain perfusion.
    Keywords 18F-florbetaben ; Positron emission tomography ; Dual-phase ; R1 ; Alzheimer’s disease ; Computer applications to medicine. Medical informatics ; R858-859.7 ; Neurology. Diseases of the nervous system ; RC346-429
    Subject code 610
    Language English
    Publishing date 2021-01-01T00:00:00Z
    Publisher Elsevier
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  6. Article ; Online: Diagnostic Performance for Differential Diagnosis of Atypical Parkinsonian Syndromes from Parkinson’s Disease Using Quantitative Indices of 18 F-FP-CIT PET/CT

    Miju Cheon / Seung Min Kim / Sang-Won Ha / Min Ju Kang / Hea-Eun Yang / Jang Yoo

    Diagnostics, Vol 12, Iss 1402, p

    2022  Volume 1402

    Abstract: ... from Parkinson’s disease (PD). We analyzed 172 subjects, including 105 non-Parkinsonism, 26 PD, 8 PSP, 1 CBD, 8 MSA-P, 9 ... phase 18 F-FP-CIT PET/CT for differential diagnosis of atypical parkinsonian syndromes (APS ... MSA-C, and 15 DLB retrospectively. Two sequential PET/CT scans were acquired at 5 min and 3 h ...

    Abstract We are aimed to evaluate the diagnostic performances of quantitative indices obtained from dual-phase 18 F-FP-CIT PET/CT for differential diagnosis of atypical parkinsonian syndromes (APS) from Parkinson’s disease (PD). We analyzed 172 subjects, including 105 non-Parkinsonism, 26 PD, 8 PSP, 1 CBD, 8 MSA-P, 9 MSA-C, and 15 DLB retrospectively. Two sequential PET/CT scans were acquired at 5 min and 3 h. We compared subregional binding potentials, putamen-to-caudate nucleus ratio of the binding potential, asymmetry index, and degree of washout. To differentiate APS, all BPs in both early and late phases (except late BPbrainstem) and all factors of the percent change except for putamen in APS significantly differed from PD. When a cut-off for early BPcerebellum was set as 0.79, the sensitivity, specificity (SP), positive predictive value (PPV), negative predictive value (NPV), and accuracy for differentiating APS 73.2%, 91.7%, 93.8%, 66.7%, and 80.0%. The early BPcerebellum showed significantly greater SP and PPV than the late quantitative indices. Combined criteria regarding both early and late indices exhibited only greater NPV. The quantitative indices showed high diagnostic performances in differentiating APS from PD. Our findings provide the dual-phase 18 F-FP-CIT PET/CT would be useful for differentiating APS from PD.
    Keywords atypical parkinsonian syndromes ; Parkinson’s disease ; dual-phase ; 18 F-FP-CIT PET ; quantitative analysis ; Medicine (General) ; R5-920
    Subject code 333
    Language English
    Publishing date 2022-06-01T00:00:00Z
    Publisher MDPI AG
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  7. Article ; Online: Characteristics and Clinical Value of 18F-FDG PET/CT in the Management of Adult-Onset Still’s Disease

    Josselin Brisset / Yvan Jamilloux / Stephanie Dumonteil / Guillaume Lades / Martin Killian / Mathieu Gerfaud-Valentin / Anne Lemaire / Tomasz Chroboczek / Eric Liozon / Guillaume Gondran / Pascal Sève / Jacques Monteil / Anne-Laure Fauchais / Kim Heang Ly

    Journal of Clinical Medicine, Vol 10, Iss 2489, p

    35 Cases

    2021  Volume 2489

    Abstract: While the diagnosis of adult-onset Still’s disease (AOSD) involves the exclusion ... coupled with CT (PET/CT) in the management of AOSD remain poorly known. Our retrospective study included ... patients from four centers, fulfilling Yamaguchi or Fautrel criteria, who underwent a PET/CT during ...

    Abstract While the diagnosis of adult-onset Still’s disease (AOSD) involves the exclusion of differential diagnoses, the characteristics and value of 18F-Fluorodeoxyglucose (18F-FDG) Positron Emission Tomography coupled with CT (PET/CT) in the management of AOSD remain poorly known. Our retrospective study included patients from four centers, fulfilling Yamaguchi or Fautrel criteria, who underwent a PET/CT during an active AOSD. Thirty-five patients were included. At the time of PET/CT, the Yamaguchi criteria were met in 23 of 29 evaluable cases. PET/CT showed bone marrow (74.3%), lymph node (74.3%), and splenic (48.6%) FDG uptake. Despite arthralgia or arthritis in most patients, joints were rarely the sites of 18F-FDG accumulation. The spatial distribution of 18F-FDG uptake was nonspecific, and its intensity could be similar to malignant disease. Lymph node or bone marrow biopsy was performed after PET/CT in 20 patients (57.1%). The intensity of bone marrow; splenic and lymph node hypermetabolism appeared to be correlated with disease activity. Abnormal PET/CT in the cervical lymph nodes and age ≥ 60 years seemed to be predictive factors for monocyclic evolution. The clinical value of PET/CT is not in direct diagnosis; but as an aid in excluding differential diagnoses by searching for their scintigraphic features and guiding biopsy.
    Keywords adult-onset Still’s disease ; 18F-FDG PET/CT ; Medicine ; R
    Subject code 610
    Language English
    Publishing date 2021-06-01T00:00:00Z
    Publisher MDPI AG
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  8. Article ; Online: Combination of automated brain volumetry on MRI and quantitative tau deposition on THK-5351 PET to support diagnosis of Alzheimer’s disease

    Minjae Kim / Sang Joon Kim / Ji Eun Park / Jessica Yun / Woo Hyun Shim / Jungsu S. Oh / Minyoung Oh / Jee Hoon Roh / Sang Won Seo / Seung Jun Oh / Jae Seung Kim

    Scientific Reports, Vol 11, Iss 1, Pp 1-

    2021  Volume 10

    Abstract: Abstract Imaging biomarkers support the diagnosis of Alzheimer’s disease (AD). We aimed ... on [18F] THK-5351 PET can aid discrimination of AD spectrum. From a prospective database in an IRB ... and 26 Alzheimer disease) with baseline structural MRI and [18F] THK-5351 PET were included. Cortical ...

    Abstract Abstract Imaging biomarkers support the diagnosis of Alzheimer’s disease (AD). We aimed to determine whether combining automated brain volumetry on MRI and quantitative measurement of tau deposition on [18F] THK-5351 PET can aid discrimination of AD spectrum. From a prospective database in an IRB-approved multicenter study (NCT02656498), 113 subjects (32 healthy control, 55 mild cognitive impairment, and 26 Alzheimer disease) with baseline structural MRI and [18F] THK-5351 PET were included. Cortical volumes were quantified from FDA-approved software for automated volumetric MRI analysis (NeuroQuant). Standardized uptake value ratio (SUVR) was calculated from tau PET images for 6 composite FreeSurfer-derived regions-of-interests approximating in vivo Braak stage (Braak ROIs). On volumetric MRI analysis, stepwise logistic regression analyses identified the cingulate isthmus and inferior parietal lobule as significant regions in discriminating AD from HC and MCI. The combined model incorporating automated volumes of selected brain regions on MRI (cingulate isthmus, inferior parietal lobule, hippocampus) and SUVRs of Braak ROIs on [18F] THK-5351 PET showed higher performance than SUVRs of Braak ROIs on [18F] THK-5351 PET in discriminating AD from HC (0.98 vs 0.88, P = 0.033) but not in discriminating AD from MCI (0.85 vs 0.79, P = 0.178). The combined model showed comparable performance to automated volumes of selected brain regions on MRI in discriminating AD from HC (0.98 vs 0.94, P = 0.094) and MCI (0.85 vs 0.78; P = 0.065).
    Keywords Medicine ; R ; Science ; Q
    Subject code 610
    Language English
    Publishing date 2021-05-01T00:00:00Z
    Publisher Nature Portfolio
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  9. Article ; Online: Machine learning identified an Alzheimer’s disease-related FDG-PET pattern which is also expressed in Lewy body dementia and Parkinson’s disease dementia

    Audrey Katako / Paul Shelton / Andrew L. Goertzen / Daniel Levin / Bohdan Bybel / Maram Aljuaid / Hyun Jin Yoon / Do Young Kang / Seok Min Kim / Chong Sik Lee / Ji Hyun Ko

    Scientific Reports, Vol 8, Iss 1, Pp 1-

    2018  Volume 13

    Abstract: Abstract Utilizing the publicly available neuroimaging database enabled by Alzheimer’s ... Winnipeg, Canada), Dong-A University Hospital (Busan, S. Korea) and Asan Medical Centre (Seoul, S. Korea ... and that it was also sensitive to other types of dementia such as Parkinson’s Disease Dementia and ...

    Abstract Abstract Utilizing the publicly available neuroimaging database enabled by Alzheimer’s disease Neuroimaging Initiative (ADNI; http://adni.loni.usc.edu/), we have compared the performance of automated classification algorithms that differentiate AD vs. normal subjects using Positron Emission Tomography (PET) with fluorodeoxyglucose (FDG). General linear model, scaled subprofile modeling and support vector machines were examined. Among the tested classification methods, support vector machine with Iterative Single Data Algorithm produced the best performance, i.e., sensitivity (0.84) × specificity (0.95), by 10-fold cross-validation. We have applied the same classification algorithm to four different datasets from ADNI, Health Science Centre (Winnipeg, Canada), Dong-A University Hospital (Busan, S. Korea) and Asan Medical Centre (Seoul, S. Korea). Our data analyses confirmed that the support vector machine with Iterative Single Data Algorithm showed the best performance in prediction of future development of AD from the prodromal stage (mild cognitive impairment), and that it was also sensitive to other types of dementia such as Parkinson’s Disease Dementia and Dementia with Lewy Bodies, and that perfusion imaging using single photon emission computed tomography may achieve a similar accuracy to that of FDG-PET.
    Keywords Medicine ; R ; Science ; Q
    Subject code 006
    Language English
    Publishing date 2018-09-01T00:00:00Z
    Publisher Nature Publishing Group
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  10. Book ; Online ; E-Book: Post mortem CT for non-suspicious adult deaths

    Shenton, Ayeshea / Kralt, Peter / Suvarna, S. Kim

    an introduction

    2021  

    Abstract: This book is an ideal introduction to the specialty of post mortem computed tomography (PMCT). It will serve as a comprehensive yet accessible guide to the understanding and interpretation of whole-body studies for both hospital and community settings. ... ...

    Author's details Ayeshea Shenton, Peter Kralt, S. Kim Suvarna
    Abstract This book is an ideal introduction to the specialty of post mortem computed tomography (PMCT). It will serve as a comprehensive yet accessible guide to the understanding and interpretation of whole-body studies for both hospital and community settings. Both normal post mortem appearances and findings associated with a wide range of diagnoses encountered in real cases from the coronial service are presented with the aid of numerous images. The coverage encompasses not only findings in all anatomic regions but also the imaging appearances in cases following targeted coronary angiography, attempted cardiopulmonary resuscitation and various special circumstances such as suicide. The inclusion of many practical tips and possible pitfalls will support the radiologist to become more confident when reporting PMCT, while for the more experienced practitioner the wealth of examples will serve as a useful resource. In addition to radiologists, the book will be of value for pathologists at all levels of experience and anyone needing to understand the role and limitations of PMCT.
    Keywords Tomography ; Tomografia ; Autòpsia
    Subject code 616.0757
    Language English
    Size 1 online resource (XI, 326 p. 455 illus., 32 illus. in color.)
    Edition 1st ed. 2021.
    Publisher Springer
    Publishing place Cham, Switzerland
    Document type Book ; Online ; E-Book
    Remark Zugriff für angemeldete ZB MED-Nutzerinnen und -Nutzer
    ISBN 3-030-70829-2 ; 3-030-70828-4 ; 978-3-030-70829-0 ; 978-3-030-70828-3
    DOI 10.1007/978-3-030-70829-0
    Database ZB MED Catalogue: Medicine, Health, Nutrition, Environment, Agriculture

    Kategorien

To top